Navigation Links
Antiviral drugs may slow Alzheimer's progression
Date:10/17/2011

Antiviral drugs used to target the herpes virus could be effective at slowing the progression of Alzheimer's disease (AD), a new study shows.

The University of Manchester scientists have previously shown that the herpes simplex virus type 1 (HSV1) is a risk factor for Alzheimer's when it is present in the brains of people who have a specific genetic risk to the disease.

AD is an incurable neurodegenerative condition affecting about 18 million people worldwide. The causes of the disease or of the abnormal protein structures seen in AD brains amyloid plaques and neurofibrillary tangles are completely unknown.

The Manchester team has established that the herpes virus causes accumulation of two key AD proteins β-amyloid (Aβ) and abnormally phosphorylated tau (P-tau) known to be the main components of plaques and tangles respectively. Both proteins are thought by many scientists to be involved in the development of the disease.

"We have found that the viral DNA in AD brains is very specifically located within amyloid plaques," said Professor Ruth Itzhaki, who led the team in the University's Faculty of Life Sciences. "This, together with the production of amyloid that the virus induces, suggests that HSV1 is a cause of toxic amyloid products and of plaques.

"Our results suggest that HSV1, together with the host genetic factor, is a major risk for AD, and that antiviral agents might be used for treating patients to slow disease progression."

Currently available antiviral agents act by targeting replication of HSV1 DNA, and so the researchers considered that they might be successful in treating AD only if the accumulation of β-amyloid and P-tau accumulation caused by the virus occurs at or after the stage at which viral DNA replication occurs.

"If these proteins are produced independently of HSV1 replication, antivirals might not be effective," said Professor Itzhaki. "We investigated th
'/>"/>

Contact: Aeron Haworth
aeron.haworth@manchester.ac.uk
44-161-275-8383
University of Manchester
Source:Eurekalert

Page: 1 2

Related medicine news :

1. UC Irvine study points to new approach to influenzas antiviral resistance
2. Arrival of direct antiviral agent therapy for hepatitis C sparks debate of who to treat first
3. Lack of health insurance limits hepatitis C patients access to latest antiviral therapy
4. New antiviral drug shows promise for dramatic improvement in hepatitis C treatment
5. Longer Antiviral Therapy Reduces Lung Transplant Complications
6. Antiviral therapy during compensated cirrhosis most cost-effective approach
7. New Study: Improved Immune System with Gene-Eden, a Natural Antiviral Supplement that Targets Chronic Viruses
8. Tests to catch the makers of dangerous legal high designer drugs
9. $8.4 million grant supports health information exchange and research on Alzheimers drugs
10. Mushroom compound appears to improve effectiveness of cancer drugs
11. Study uncovers why anti-rejection drugs for transplant patients cause hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Raleigh, NC (PRWEB) June 03, 2015 ... on two biomarkers for mesothelioma and say the tried-and-true ... has just posted an article on the research. ... in the University’s National Center for Asbestos Related Diseases ... false positive results, it is still preferable to fibulin-3 ...
(Date:6/3/2015)... June 03, 2015 Sitting at a ... discomfort in the back, neck, shoulders and/or wrists. This ... injuries. In addition, recent research links sitting for long ... chronic diseases. Fortunately, three inventors from Oakville, Ontario, are ... a desk. , They have developed a prototype for ...
(Date:6/3/2015)... On Sunday, June 7, 2015, tens of ... their local communities to observe the 28th annual National ... and abroad will hold celebrations on this day to ... challenges of cancer survivorship, and to show the world ... rewarding, and inspiring.,  , National Cancer Survivors Day® is ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Fourroux Prosthetics, ... Duluth, GA will celebrate its grand opening with a ... The first prosthetic center of its kind in the ... family unmatched care and outcomes through use of patented ... CPO & CEO of Fourroux Prosthetics, states, “Our goal ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 These are ... sectors. The ever growing number of digital-first business are ... There is now a serious need for traditional businesses ... way they operate and deliver their services. On ... partnerships between incumbents and technology start-ups, to bring new ...
Breaking Medicine News(10 mins):Health News:Analysis Reveals Gold Standard Mesothelioma Biomarker Still the Best, According to Surviving Mesothelioma 2Health News:Adjustable Height Tabletop Unit Invented by Three InventHelp® Clients (TOR-9278) 2Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 2Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 3Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 4Health News:Fourroux Prosthetics Atlanta to Have Grand Opening Gala & Ribbon Cutting Ceremony 2Health News:Chief Digital Officer of Travelex joins Bayer, Abellio and Just Eat at The Open Mobile Summit London 2
... The Cardinal Health Foundation today announced that it ... a $100,000 grant to create education and outreach programs ... medication abuse and misuse in their communities. , According ... quarter of all Ohio high school students have reported ...
... LONDON, October 28 Even though no-one wants to admit it,the countdown ... at the,ubiquitous Christmas Party then follow the realbuzz.com guide to a healthier,you. ... living go out,the window, so now,s the time to turn your body ... be realbuzz.com if we didn,t offer this piece of,advice to start with! ...
... ... keys to exceptional marketing performance at your fingertips with his new web seminar hosted ... them will help pharmaceutical marketers understand what they can do to improve the effectiveness ... ...
... Ill., Oct. 28 Understanding the needs of patients ... providers, including enhancing safety and helping to stem the ... fact, many academic medical centers are turning to implementation ... quality of care for patients. , The Institute ...
... Oct. 27 Dr. Michael Feiz , lead surgeon at ... Lap Band surgeries than any other doctor. For ... is the answer they have been looking for to shed the ... with almost no scarring, Lap Band surgery has the ...
... Oct. 27 The St. Louis Cardinals, new hire of ... coach sends a message to all baseball and young people ... ," former White House drug policy spokesman Bob Weiner said ... the drugs? When McGwire used Andro (Androstenedione), now banned, he ...
Cached Medicine News:Health News:Cardinal Health Foundation, The Ohio State University College of Pharmacy Join Forces to Prevent Prescription Medication Abuse 2Health News:The Countdown to Christmas - The realbuzz.com Guide to a Healthier You! 2Health News:5 Steps to Pharmaceutical Marketing Happiness 2Health News:UHC Benchmarking Project Focuses on Patient- and Family-Centered Care in Academic Medical Centers 2Health News:UHC Benchmarking Project Focuses on Patient- and Family-Centered Care in Academic Medical Centers 3Health News:Beverly Hills Doctor (drfeiz.com) Performs the World's Most Lap Band Surgeries 2Health News:Mark McGwire's Message: Cheat, Do Drugs, Cover Up When Congress Investigates, Says Ex-White House Drug Spokesman Bob Weiner; World Series Should Test Both Teams During Games 2
(Date:6/3/2015)... Research and Markets  ( http://www.researchandmarkets.com/research/rf4hfn/global ) ... Neurodegenerative Diseases Market 2015-2019" report to their ... to grow at a CAGR of 4.77% over ... the present scenario and the growth prospects of ... 2015-2019. To calculate the market size, the report ...
(Date:6/3/2015)... June 3, 2015  EIP Pharma LLC ( www.eippharma.com ... clinical development of VX-745 in Alzheimer,s disease (AD) is ... and potent inhibitor of the alpha isoform of the ... alpha). "Recent human genetic data demonstrate that ... with symptomatic Alzheimer,s, while the science also indicates the ...
(Date:6/3/2015)... , June 02, 2015 Research and ... the "Europe Ultrasound Devices Market - Growth, Trends ... offering. Currently, the European market is dominated ... of France and ... increasing incidences of chronic diseases in these regions. ...
Breaking Medicine Technology:Global Neurodegenerative Diseases Market 2015-2019 - Reformulation of Marketed Drugs 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 3European Ultrasound Devices Market Report 2015-2019 2
... May 4, 2012  PRO-DEX, INC. (NasdaqCM: PDEX) today announced ... months ended March 31, 2012. (Logo: ... reported a loss from continuing operations of $513,000, or ... 31, 2012 compared to income from continuing operations of ...
... (NASDAQ: AMGN ) will present at the Baird ... Four Seasons Hotel, Chicago, Ill., beginning at 8:20 a.m. Central ... Amgen, will present. Live audio of the presentation can be ... , under Investors. About Amgen ...
Cached Medicine Technology:Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results 2Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results 3Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results 4Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results 5Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results 6Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results 7Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results 8
Designated most popular model or size. 3 mm tip....
Designated most popular model or size. Double-ended. 2 mm wide....
Designated most popular model or size. Slightly angled, 2 mm wide....
4 mm x 6 mm dissector end with shaft marked at 10 mm, 20 mm, 30 mm from tip. 6 mm wide curved elevator. Round knurled handle....
Medicine Products: